Working toward drug plan sustainabilityBiosimilars, generics among tools that can help ensure employee healthBy Jason Kennedy10/01/2019|Canadian HR Reporter|Last Updated: 10/01/2019 Health care remains a fundamental and defining issue for Canadians. As such, ensuring that private drug plans evolve with Canada’s changing health-care landscape is of great importance. It is critical that plan sponsors have the right information to ensure employee health benefits continue to support the best possible health outcomes for the workforce, while ensuring sustainability as the rising costs of medications remains a constant challenge. We are not just living longer in Canada, we’re now working longer, too. Chronic diseases and increased utilization are contributing factors to growing prescription claims costs amid the already high costs of drug plans in Canada. To Read the Full Story, Subscribe or Sign In Remember Me Forgot Password If you are a current Subscriber, please click here to set-up or update your login information.